Sio Capital Management’s Boundless Bio BOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-163,679
Closed -$180K 91
2026
Q1
$180K Hold
163,679
0.03% 68
2025
Q4
$196K Hold
163,679
0.03% 65
2025
Q3
$201K Hold
163,679
0.05% 46
2025
Q2
$165K Buy
163,679
+1,621
+1% +$2.15K 0.06% 47
2025
Q1
$245K Hold
162,058
0.07% 50
2024
Q4
$470K Hold
162,058
0.13% 43
2024
Q3
$562K Hold
162,058
0.22% 31
2024
Q2
$627K Buy
162,058
+19,058
+13% +$182K 0.17% 41
2024
Q1
$2.04M Buy
+143,000
New +$2.04M 0.61% 37

Other funds holding BOLD

Sio Capital Management's BOLD Position: Q2 2026 in Review

Sio Capital Management sold out of Boundless Bio (BOLD) in Q2 2026, closing a stake of 163,679 shares — an estimated $180K sold.

Sio Capital Management first reported a position in BOLD in Q1 2024 and held it in 9 quarters. The position peaked at $2.04M in Q1 2024. 40 funds tracked by Wall St. Rank hold BOLD as of Q2 2026.

  • Sio Capital Management reported no remaining Boundless Bio position as of Q2 2026 after selling out during the quarter.
  • Sio Capital Management sold 163,679 Boundless Bio shares in Q2 2026, an estimated $180K.
  • Sio Capital Management first reported a position in Boundless Bio in Q1 2024 and held it in 9 quarters.
  • Sio Capital Management's Boundless Bio position peaked at $2.04M in Q1 2024.
  • 40 funds tracked by Wall St. Rank held Boundless Bio as of Q2 2026.

Based on Sio Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.